Joint Formulary & PAD

Buprenorphine - Opioid dependence

You are here : Home > Formulary Search > Buprenorphine - Opioid dependence

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Implant
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
NFD2
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Buprenorphine
Indication :
Opioid dependence
Group Name :
Keywords :
Brand Names Include :
Sixmo
Important Information :

Buprenorphine implant has not been assessed for inclusion on the formulary. Please contact Pharmacy for advice.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

02 Mar 22 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

This drug / device has not yet been assessed for formulary status and is not currently on the APC work-plan.

This drug / device has not yet been evaluated by the Surrey Heartlands Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing this drug / device.
The APC will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicans can contact syheartlandsccg.APC@nhs.net  if they wish to make a submission.
 

Other Indications

Below are listed other indications that Buprenorphine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Opioid dependence.

  • No records returned.